First-line chemotherapy in low-risk gestational trophoblastic neoplasia-Reference-Cited by-同舟云学术

First-line chemotherapy in low-risk gestational trophoblastic neoplasia

Published:2016-06-09 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Lawrie Theresa A¹,Alazzam Mo'iad²,Tidy John³,Hancock Barry W⁴,Osborne Raymond⁵

Affiliation:

1. 1st Floor Education Centre, Royal United Hospital; Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group; Combe Park Bath UK BA1 3NG

2. Beacon Hospital; Gynaecological Oncology Division; Sandyford Dublin Ireland 18

3. Sheffield Teaching Hospitals Foundation NHS Trust; Obstetrics & Gynaecology; Royal Hallamshire Hospital Glossop Road Sheffield UK S10 2JF

4. Sheffield University; School of Medicine and Biomedical Sciences; Western Bank Sheffield UK S10 2TN

5. Toronto-Sunnybrook Regional Cancer Centre; Division of Gynecology-Oncology; 2075 Bayview Ave Toronto ON Canada M4N 3M5

Publisher

Wiley

Subject

Pharmacology (medical)

Reference82 articles.

1. Gilani MM Yarandi F Eftekhar Z Hanjani P Comparison of pulse methotrexate and pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia Australian and New Zealand Journal of Obstetrics and Gynaecology 2005 161 4

2. Lertkhachonsuk A Tangtrakul S Israngura N Wilailak S Actinomycin D versus methotrexate-folinic acid as the treatment of stage 1, low-risk gestational trophoblastic neoplasia Conference abstract from the International Society for the Study of Trophoblastic Disease (ISSTD) conference 2007

3. Actinomycin d versus methotrexate-folinic acid as the treatment of stage I, low-risk gestational trophoblastic neoplasia: a randomized controlled trial;Lertkhachonsuk;International Journal of Gynecological Cancer,2009

4. Comparison of pulsed actinomycin D versus 5-day methotrexate for the treatment of low-risk gestational trophoblastic disease;Mousavi;International Journal of Gynecology and Obstetrics,2012

5. Osborne R Filiaci V Schink J Mannel R Provencher D Alvarez-Secord A A randomized phase III trial comparing weekly parenteral methotrexate and “pulsed” actinomycin D as primary management for low-risk gestational trophoblastic neoplasia: A Gynecologic Oncology Group study Gynecologic Oncology 2008 S2 S31

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hysterectomy versus chemotherapy for low-risk non-metastatic gestational trophoblastic neoplasia (GTN): A cost-effectiveness analysis;Gynecologic Oncology;2024-08

2. Integrating High-intensity Focused Ultrasound with Chemotherapy for the Treatment of Invasive Hydatidiform Mole in Reproductive-age Women;Gynecology and Minimally Invasive Therapy;2024-07

3. First-line monodrug chemotherapy in low-risk gestational trophoblastic neoplasia: a network meta-analysis;Frontiers in Oncology;2024-01-05

4. Invasive and metastatic hydatidiform moles in Slovakia in 1993-2022;BRATISL MED J;2024

5. Pneumocystis jirovecii pneumonia complicating methotrexate treatment in a patient with low-risk post-molar gestational trophoblastic neoplasia: A case report and review of the literature;Gynecologic Oncology Reports;2023-12